A Phase IIb Pilot Study to Assess the Efficacy, Safety and Pharmacodynamics Effects of Pembrolizumab and BL-8040 in Patients With Metastatic Pancreatic Cancer

Trial Profile

A Phase IIb Pilot Study to Assess the Efficacy, Safety and Pharmacodynamics Effects of Pembrolizumab and BL-8040 in Patients With Metastatic Pancreatic Cancer

Recruiting
Phase of Trial: Phase II

Latest Information Update: 10 Feb 2017

At a glance

  • Drugs BL 8040 (Primary) ; Pembrolizumab (Primary)
  • Indications Pancreatic cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Dec 2016 Status changed from not yet recruiting to recruiting.
    • 15 Sep 2016 Status changed from planning to not yet recruiting.
    • 22 Aug 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top